drugset / Trial / NCT02184351

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

NCT02184351

Phase 3 Completed 187 enrolled Boehringer Ingelheim
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this study are to compare the efficacy and safety of Roxane's clotrimazole troches vs. Mycelex troches in HIV positive patients with oropharyngeal candidiasis, where this condition has been diagnosed by clinical examination and confirmed by fungal culture.

Timeline

Start
2001-05
Primary completion
2001-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Clotrimazole Unknown 10 mg

Indications